Hairui Wang

Jan 12, 2025 | onlinelibrary.wiley.com | Hairui Wang |Hongbo Gao |Xu Liu

Median sternal incision is a common surgical approach in cardiac surgery [1]. And the infection of the median sternal incision is also a common problem in the clinical work of cardiac surgeons. The infection of the median sternal incision after operation may aggravate the patient's condition and even cause death.

Apr 4, 2024 | onlinelibrary.wiley.com | Hairui Wang |Shuang Luo |Mingxin Xie |Zhao Chen

Jincun Zhao State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510182 P. R. ChinaSearch for more papers by this author

Jan 4, 2024 | onlinelibrary.wiley.com | Hairui Wang |Shuang Luo |Mingxin Xie |Zhao Chen

Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adma202311537-sup-0001-SuppMat.pdf2.9 MB Supporting Information References 1, , , , , J. Hepatol. 2021, 74, 168. 2, Drugs 2020, 80, 1355. 3, , , , , , , Expert Rev. Clin. Pharmacol. 2021, 14, 95. 4, , , , , , , , Acta Pharmacol. Sin. 2021, 42, 1195. 5a) , , , , , , , , JCI Insight 2019, 4, e127474; b) , , Immunol. Lett. 2002, 84, 63.

Jan 4, 2024 | pericles.pericles-prod.literatumonline.com | Hairui Wang |Shuang Luo |Zhao Chen |Mingxin Xie

Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adma202311537-sup-0001-SuppMat.pdf2.9 MB Supporting Information References 1, , , , , J. Hepatol. 2021, 74, 168. 2, Drugs 2020, 80, 1355. 3, , , , , , , Expert Rev. Clin. Pharmacol. 2021, 14, 95. 4, , , , , , , , Acta Pharmacol. Sin. 2021, 42, 1195. 5a) , , , , , , , , JCI Insight 2019, 4, e127474; b) , , Immunol. Lett. 2002, 84, 63.

Jun 9, 2023 | frontiersin.org | Hairui Wang |Peng Zhang

Introduction Venous thromboembolism (VTE) is a disease with high morbidity and a high risk of death (1). Reportedly, there are ~10 million cases of VTE annually worldwide (2), and the incidence of VTE can be as high as 0.2% per year (3). VTE has become the third leading cause of cardiovascular disease-related death (4). Effective prevention of VTE can significantly reduce its incidence, and VTE risk assessment plays a crucial role in clinical practice (5).